@article{babd74a0646a4c808e6c6971073a352d,
title = "Patient-Reported Outcomes in Dermatology",
author = "Kirby, {Joslyn S.}",
note = "Funding Information: support from the Agency for Healthcare Research and Quality and the International Dermatology Outcome Measures during the development of the Hidradenitis Suppurativa Quality of Life (HiSQoL) and the Hidradenitis Suppurativa Area and Severity Index (HASI) and patents for the HiSQoL, HASI, and the HASI-revised instruments, licensed by Penn State University, during the conduct of this work. In addition, Dr Kirby reported speaking honoraria from AbbVie; serving on the advisory boards of AbbVie, Incyte, Novartis, and Janssen; and consulting fees from Bayer, ChemoCentryx, DermTech, Incyte, InflaRx, Janssen, Novartis, and Union Chimique Belge, all outside of the submitted work.",
year = "2022",
month = jan,
doi = "10.1001/jamadermatol.2021.1559",
language = "English (US)",
volume = "158",
pages = "97--98",
journal = "JAMA Dermatology",
issn = "2168-6068",
publisher = "American Medical Association",
number = "1",
}